Concentration	9 Months Ended
Concentration	Sep. 30, 2023
Risks and Uncertainties [Abstract]
Concentration	Concentration On December 14, 2022, the Company received a modification to the Company’s current agreement with the U.S. Department of Health and Human Services (“HHS”) and the Assistant Secretary for Preparedness and Response (“ASPR”) was due to expire on February 27, 2023 incorporating Federal Acquisition Regulation (“FAR”) 52.217-8, which resulted in the government extending the term of this current agreement to August 27, 2023. Additionally, on December 14, 2022, the Company entered into a new agreement with HHS/ASPR (the "Agreement") for preventive maintenance services (“PMS”), management and storage for ventilator and powered air purifying respirator (“PAPR”) systems. The Agreement’s performance period commenced on August 28, 2023 and is anticipated to have a period of performance of four years and six months, consisting of a base period of twelve months, three one-year option periods and an additional six-month option period. Revenue related to various contracts with HHS/ASPR represented 10.4% of total revenue for both the three months ended September 30, 2023 and 2022, and 10.5% and 10.8% of total revenue for the nine months ended September 30, 2023 and 2022, respectively.

AGILITI, INC. \DE 10-Q